9 Biotech and Pharma Stocks Flashing the Strongest Buy Signals Right Now (April 2026)

9 Biotech and Pharma Stocks Flashing the Strongest Buy Signals Right Now, Based on Today’s Screen

Biotech and pharma stocks are showing a mixed setup right now, but a handful of names stand out with the strongest technical scores, improving momentum, and clearer entry structures. Based on the latest screen you shared, MDGL, TERN, EWTX, SRPT, PTGX, AGIO, EXAI, CDXS, and UTHR are among the names showing the most actionable bullish signals, while several others are either extended, overbought, or still better left on watchlist status.

Biotech Stocks Showing the Best Buy Signals Today

The strongest setups from this screen are the stocks combining high scores, bullish MACD signals, improving trend structure, and a valid entry or trend-continuation trigger.

Top actionable names from the screen

Quick answer: Which stocks look strongest?

If the goal is to find the highest-conviction bullish biotech setups from this screen, the leaders are:

1. MDGL
2. TERN
3. SRPT
4. UTHR
5. EWTX
6. PTGX
7. AGIO
8. EXAI
9. CDXS

These names either ranked near the top of the screen, carried a Strong Buy signal, or showed stronger entry confirmation than most of the broader list.

Why MDGL Is the Strongest Setup on This Screen

MDGL ranks No. 1 on the list

MDGL is the top-ranked stock in your screen with a Score of 15, a Strong Buy signal, and an Entry Type of Trend continuation. It is trading at $523.47, with bullish MACD, rising OBV, strong Aroon behavior, and a 77% confidence level.

Key MDGL levels

• Entry zone: Extended — wait for pullback
• Target 1: $575.52
• Target 2: $601.54
• Target 3: $602.83
• Stop loss: $484.44
• Trail stop: $430.10

MDGL takeaway

MDGL looks like the strongest name on the board, but it is also not a low-risk chase after the recent move. The screen itself suggests a pullback entry rather than aggressive buying at current levels.

TERN, SRPT, and UTHR Are High-Conviction Momentum Leaders

Several biotech names are showing strong trend-continuation setups rather than early-stage reversals.

TERN

• Price: $52.72
• Score: 13
• Signal: Strong Buy
• Confidence: 77%
• RSI: 75.5

TERN has one of the strongest signals on the list, but it is also clearly overbought. The screen flags Take Profit conditions because RSI is elevated. That makes it a strong stock, but not necessarily an ideal fresh chase.

SRPT

• Price: $21.76
• Score: 13
• Signal: Strong Buy
• Confidence: 77%

SRPT is another high-ranking name with bullish trend continuation characteristics. The stock has strong recent returns and improving momentum, though it also needs disciplined stop placement because volatility remains high.

UTHR

• Price: $592.98
• Score: 12
• Signal: Strong Buy
• Confidence: 77%

UTHR is one more top-tier trend name. It is trading at highs with bullish momentum, but the screen also labels it as Take Profit / overbought, which means the setup is strong, yet less attractive for late entries.

Best Breakout Candidates in the Biotech and Pharma Space

Some stocks on the screen are not just trending; they are sitting in more defined breakout-style zones.

EWTX looks clean for breakout traders

EWTX stands out because it combines:

• Score: 13
• Strong Buy signal
• Breakout entry type
• Target 1: $34.73
• Entry zone: $27.75 – $29.97
• Stop loss: $29.08

The current price of $31.50 puts it above the entry zone, but it still looks cleaner than many names that are deeply extended.

PTGX remains one of the stronger mid-cap biotech setups

PTGX is trading at $105.40 with a Score of 11 and a Strong Buy signal. It also has bullish MACD and rising OBV, which supports the current move.

Key levels:

• Entry zone: $90.32 – $97.88
• Target 1: $114.91
• Target 2: $119.66
• Stop loss: $98.27

PTGX remains strong, though it is closer to momentum-chasing territory now than ideal early entry.

AGIO is strong but stretched

AGIO has:

• Price: $33.83
• Score: 11
• Strong Buy
• RSI: 75.8

That is a powerful setup on paper, but the stock is already extended. It is better described as a strong stock needing a better entry rather than a perfect buy-at-any-price candidate.

Hidden Small-Cap Movers Worth Watching

Not every strong signal is coming from the large-cap biotech names. A few smaller stocks also look interesting from a pure technical perspective.

EXAI

EXAI is notable because it carries a Strong Entry tag with 5 of 6 conditions met and 73% confidence. At $1.70, it is one of the cleaner small-cap momentum names on the list, though risk remains much higher than in larger names.

CDXS

CDXS is even more interesting from a signal-confirmation perspective:

• Price: $1.63
• Signal: Strong Buy
• Entry Signal: Strong Entry
• Confidence: 88%

That confidence reading is one of the highest in the entire screen. For aggressive traders, this is the kind of lower-priced biotech name that may attract attention quickly.

Stocks That Look Good but May Be Better on Watchlist

Several biotech and pharma names have bullish labels, but the reward-to-risk or current extension makes them less attractive for immediate entries.

Examples of “watch, don’t chase” names

• SNY – Strong Buy, but already extended and flagged to tighten stops
• INSM – Strong setup, but also extended after a strong run
• CPRX – Bullish breakout structure, but not especially favorable after the move
• XBI – Broad biotech ETF looks constructive, but the setup is less explosive than the best single-stock names
• IBB – Similar story to XBI, solid but less compelling than top-ranked individual names
• REGN – Strong score, but the screen itself notes poor risk/reward
• AZN – Bullish, yet not as attractive as the highest-ranked biotech movers

Biotech Stocks to Avoid Right Now

The screen also makes it clear that not every sharp move deserves attention on the long side.

Weakest setups from the list

These names are still in downtrend or “avoid” territory:

• ALT
• SGMO
• SANA
• RXRX
• OGEN
• KALA
• MDXH
• RCKT
• LABD
• PHGE

These stocks either carry Strong Sell signals, downtrend confirmation, or explicit Exit Now / Avoid language in the screen.

Featured Snippet: Best biotech stocks from this screen today

Which biotech stocks have the strongest buy signals right now?

Based on the screen provided, the biotech and pharma stocks with the strongest buy signals are MDGL, TERN, SRPT, UTHR, EWTX, PTGX, AGIO, EXAI, and CDXS. These names stand out for their high scores, bullish MACD calls, valid entry structures, and stronger confidence readings than the rest of the list.

Final Take

The clearest takeaway from this biotech and pharma screen is that strength is concentrated in a small number of names, not spread evenly across the sector.

MDGL is the strongest overall setup.
TERN, SRPT, and UTHR are the strongest trend-continuation names.
EWTX and PTGX look like some of the cleaner breakout candidates.
EXAI and CDXS stand out as aggressive small-cap momentum plays with unusually strong confirmation readings.

At the same time, many names on the list are still better treated as watchlist stocks rather than immediate buys, especially where the screen itself warns that the move is extended or that risk/reward remains weak.

Disclaimer: This article is for informational purposes only and does not constitute financial or investment advice. Stock signals and technical indicators can change rapidly and do not guarantee future performance. Always do your own research or consult a qualified financial advisor before investing.